Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
breast-cancertriple-negative-breast-cancer
breast cancer, triple-negative breast cancer, anti-pd-1 antibody, vegfr2 tki, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 839634
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.